top of page
News, Events and Updates
Search
Anavex Appoints Contract Research Organizations to Initiate Phase I/IIa Clinical Programs
Aug 10, 2010
Anavex Reports Animal Study Results as Lead Alzheimer’s Compound Approaches Phase 1 Clinical Trials
May 4, 2010
Anavex Comments on Failure of Pfizer and Medivation’s Dimebon
Mar 3, 2010
Anavex Appoints Dr. Cameron Durrant Executive Chairman of the Board
Jan 18, 2010
Anavex Contracts FORENAP Pharma for Pre-Clinical Trials of ANAVEX 2-73 in Alzheimer's Disease
Sep 30, 2009
Anavex Completes Scale-Up Manufacturing of ANAVEX 2-73 for Phase I AD Clinical Trials
Sep 21, 2009
Anavex Reports Sigma Receptor Review Published in Leading Journal
Aug 27, 2009
ANAVEX Appoints Dr. Hervé de Kegrohen as CEO to Lead Company Through Clinical Trials & Future Growth
Jun 16, 2009
Pharmawire: Medivation, Anavex May Lower Oxidative Stress
Apr 8, 2009
Anavex Appoints Leading Alzheimer’s Disease Expert Dr. Mark Smith to Scientific Advisory Board
Feb 10, 2009
Anavex Scales Up Synthesis of ANAVEX 2-73 for Phase 1 Alzheimer’s Disease Study
Jan 30, 2009
46
47
48
49
50
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
